This test is most useful if any of these apply to you.
Urinary 3-hydroxyisovaleric acid can rise when your body has too little biotin to process leucine efficiently. Small controlled feeding studies showed this biochemical change while blood biotin measurements remained relatively unchanged. That makes it useful supporting evidence when a biotin shortfall is suspected, but several other causes can produce the same result.
Its established clinical role is within urine organic acid profiles used to investigate inherited metabolic disorders. Its use for detecting marginal biotin deficiency rests mainly on small human studies. Routine screening, personal optimization targets, and repeated testing to improve long-term health haven't been established.
Leucine is an amino acid used to build proteins. Your body also breaks it down through a series of chemical reactions. One step requires both biotin and an enzyme called 3-methylcrotonyl-CoA carboxylase, or MCC. When that step slows, more of the material entering the pathway can be converted into 3-HIA and leave through your urine.
A related compound, 3-hydroxyisovaleryl carnitine, forms when the same chemical group is attached to carnitine. It is a separate molecule with its own measurements and evidence. This urine result concerns the free acid.
In controlled studies, adults ate diets designed to reduce biotin availability. Urinary 3-HIA increased over several weeks, while serum biotin was a less sensitive indicator of the early change. These experiments establish that inadequate biotin can raise urinary 3-HIA. They don't establish that biotin deficiency is the most common explanation for an elevated result in everyday practice.
The marker also performed better than two other organic acids examined in these experiments. Urinary 3-hydroxypropionic acid identified only 5 of 21 volunteers with experimentally induced marginal deficiency. Methylcitric acid was inconsistent between studies. Among these organic acids, 3-HIA was the most sensitive indicator.
Much of this evidence comes from timed urine collections under controlled conditions. A single sample collected during ordinary life has more uncertainty around recent food intake, supplements, and urine concentration. There is no universally accepted preventive target, and a personal baseline doesn't resolve those limitations.
Pregnancy studies also support a relationship between increased urinary 3-HIA and reduced biotin availability. They measured biochemical responses, however, and didn't establish that screening with this marker improves pregnancy outcomes. An elevated result isn't evidence that a baby has been harmed.
Several inherited disorders can raise urinary 3-HIA. The accompanying acids help distinguish them because each disorder interrupts a different part of metabolism.
Severe forms can present in infancy, but milder or later presentations occur. Newborn screening uses different markers for different disorders. C5-OH is relevant to MCC deficiency and several related conditions, C5 is used in screening for isovaleric acidemia, and biotinidase screening measures enzyme activity. None is the same measurement as free 3-HIA in urine.
Many people identified with MCC deficiency through newborn screening remain well despite pronounced biochemical abnormalities. Published screening experience suggests that more than nine in ten identified individuals appear to remain asymptomatic, although follow-up duration and ascertainment vary. A high urinary value therefore cannot predict an individual's clinical course.
The diagnosis, symptoms, companion metabolites, and response to illness matter. A substantial elevation can occur without symptoms, while an inherited disorder can sometimes produce a less striking profile between episodes.
A study of 694 kidney transplant recipients measured 3-hydroxyisovaleryl carnitine in 24-hour urine, a related but different measurement. Higher excretion was associated with lower mortality during follow-up. Protein intake and muscle-related measures explained much of the variation, and accounting for those factors weakened the mortality association.
That finding doesn't establish a survival relationship for free urinary 3-HIA or show that raising either marker improves health. It does show why findings about the carnitine-bound molecule shouldn't be used as direct evidence about this test.
Ketoacidosis can increase urinary 3-HIA. This is a dangerous disturbance in which ketones accumulate and make the blood too acidic. Studies found that urinary 3-HIA increased alongside the ketone 3-hydroxybutyrate, so an elevated result in that setting doesn't establish nutritional biotin deficiency.
An exploratory study also found increased urinary 3-HIA in children being treated for tuberculous meningitis. It used an NMR research method and compared a small group of affected children with controls. Its results haven't established this routine urine measurement as a test for meningitis or a general measure of illness severity.
Evidence-backed interventions that affect your 3-Hydroxyisovaleric Acid level
3-Hydroxyisovaleric Acid is best interpreted alongside these tests.
3-Hydroxyisovaleric Acid is included in these pre-built panels.
See the chemical trail your metabolism leaves behind, and explore where your energy, gut, and nutrient pathways may be under strain.
A comprehensive at-home nutritional and metabolic assessment that analyzes key biomarkers to reveal functional nutrient needs and imbalances.
90 biomarkers